175 filings
Page 2 of 9
8-K
7k5o7ym19iurfqsby5i
15 Jun 21
AtriCure Names Two New Members to the Board of Directors
7:02am
8-K
tumk rh5vaqoxrrhmzjb
24 May 21
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
u28j6ay6
29 Apr 21
AtriCure’s EPi-Sense System Approved by FDA
7:00am
8-K
42rjivj6g53ag6baf
27 Apr 21
AtriCure Reports First Quarter 2021 Financial Results
4:00pm
8-K
j80lxh4gvmmixjo3ev
8 Apr 21
AtriCure Names B. Kristine Johnson Board Chair
8:00am
8-K
p35chj7f
23 Feb 21
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
4:01pm
8-K
ohcknphiqs9z94zmpkzn
11 Jan 21
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
7:00am
8-K
kxv0xji7
5 Nov 20
AtriCure Reports Third Quarter 2020 Financial Results
4:07pm
8-K
oro96quj
6 Aug 20
AtriCure Announces Angie Wirick as Chief Financial Officer
4:16pm
8-K
ywo2lsoow yj
28 Jul 20
AtriCure Reports Second Quarter 2020 Financial Results
4:03pm
8-K
qvj4edp2o
22 May 20
Departure of Directors or Certain Officers
11:46am
8-K
ltzr8clsdidqzf0qw2
13 May 20
AtriCure Announces Proposed Public Offering of Common Stock
12:00am
8-K
3hwzg
8 May 20
AtriCure Announces Results from CONVERGE IDE Clinical Trial
8:55am
8-K
w109k5mx
29 Apr 20
AtriCure Reports First Quarter 2020 Financial Results
4:05pm
8-K
pargx
13 Apr 20
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
8:00am
8-K
2qz3tc4frdysac
9 Apr 20
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
8:00am
8-K
634p2b 0u4o
18 Feb 20
AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results
4:08pm
8-K
iynus
13 Jan 20
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019
8:06am
8-K
qge2ksp9028ckd
4 Dec 19
AtriCure Names Two Industry Veterans to Board of Directors
8:05am
8-K
pgd0pv5 a8ge
30 Oct 19
AtriCure Reports Third Quarter 2019 Financial Results
4:06pm